139 related articles for article (PubMed ID: 29165602)
1. Deletion of connective tissue growth factor ameliorates peritoneal fibrosis by inhibiting angiogenesis and inflammation.
Toda N; Mori K; Kasahara M; Koga K; Ishii A; Mori KP; Osaki K; Mukoyama M; Yanagita M; Yokoi H
Nephrol Dial Transplant; 2018 Jun; 33(6):943-953. PubMed ID: 29165602
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis.
Sakai N; Nakamura M; Lipson KE; Miyake T; Kamikawa Y; Sagara A; Shinozaki Y; Kitajima S; Toyama T; Hara A; Iwata Y; Shimizu M; Furuichi K; Kaneko S; Tager AM; Wada T
Sci Rep; 2017 Jul; 7(1):5392. PubMed ID: 28710437
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of 1,25(OH)2-VitaminD3 on fibrosis and angiogenesis of peritoneum induced by chlorhexidine.
Da J; Yang Y; Dong R; Shen Y; Zha Y
Biomed Pharmacother; 2020 Sep; 129():110431. PubMed ID: 32585450
[TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor is correlated with peritoneal lymphangiogenesis.
Kinashi H; Toda N; Sun T; Nguyen TQ; Suzuki Y; Katsuno T; Yokoi H; Aten J; Mizuno M; Maruyama S; Yanagita M; Goldschmeding R; Ito Y
Sci Rep; 2019 Aug; 9(1):12175. PubMed ID: 31434958
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
[TBL] [Abstract][Full Text] [Related]
6. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through β-catenin signaling.
Padwal M; Siddique I; Wu L; Tang K; Boivin F; Liu L; Robertson J; Bridgewater D; West-Mays J; Gangji A; Brimble KS; Margetts PJ
Nephrol Dial Transplant; 2017 Jan; 32(1):50-61. PubMed ID: 27190383
[TBL] [Abstract][Full Text] [Related]
8. Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis.
Washida N; Wakino S; Tonozuka Y; Homma K; Tokuyama H; Hara Y; Hasegawa K; Minakuchi H; Fujimura K; Hosoya K; Hayashi K; Itoh H
Nephrol Dial Transplant; 2011 Sep; 26(9):2770-9. PubMed ID: 21378147
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice.
Yokoi H; Kasahara M; Mori K; Kuwabara T; Toda N; Yamada R; Namoto S; Yamamoto T; Seki N; Souma N; Yamaguchi T; Sugawara A; Mukoyama M; Nakao K
Perit Dial Int; 2013; 33(2):143-54. PubMed ID: 23123666
[TBL] [Abstract][Full Text] [Related]
10. Crucial Role of Mesangial Cell-derived Connective Tissue Growth Factor in a Mouse Model of Anti-Glomerular Basement Membrane Glomerulonephritis.
Toda N; Mori K; Kasahara M; Ishii A; Koga K; Ohno S; Mori KP; Kato Y; Osaki K; Kuwabara T; Kojima K; Taura D; Sone M; Matsusaka T; Nakao K; Mukoyama M; Yanagita M; Yokoi H
Sci Rep; 2017 Feb; 7():42114. PubMed ID: 28191821
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Transglutaminase 2 Reduces Peritoneal Injury in a Chlorhexidine-Induced Peritoneal Fibrosis Model.
Kunoki S; Tatsukawa H; Sakai Y; Kinashi H; Kariya T; Suzuki Y; Mizuno M; Yamaguchi M; Sasakura H; Ikeno M; Takeuchi K; Ishimoto T; Hitomi K; Ito Y
Lab Invest; 2023 Apr; 103(4):100050. PubMed ID: 36870292
[TBL] [Abstract][Full Text] [Related]
12. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
14. Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis.
Makino K; Makino T; Stawski L; Lipson KE; Leask A; Trojanowska M
Arthritis Res Ther; 2017 Jun; 19(1):134. PubMed ID: 28610597
[TBL] [Abstract][Full Text] [Related]
15. LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.
Sakai N; Chun J; Duffield JS; Wada T; Luster AD; Tager AM
FASEB J; 2013 May; 27(5):1830-46. PubMed ID: 23322166
[TBL] [Abstract][Full Text] [Related]
16. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model.
Yoshio Y; Miyazaki M; Abe K; Nishino T; Furusu A; Mizuta Y; Harada T; Ozono Y; Koji T; Kohno S
Kidney Int; 2004 Oct; 66(4):1677-85. PubMed ID: 15458466
[TBL] [Abstract][Full Text] [Related]
17. The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.
Ferrantelli E; Liappas G; Vila Cuenca M; Keuning ED; Foster TL; Vervloet MG; Lopéz-Cabrera M; Beelen RH
Kidney Int; 2016 Mar; 89(3):625-35. PubMed ID: 26880457
[TBL] [Abstract][Full Text] [Related]
18. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
Ertilav M; Hur E; Bozkurt D; Sipahi S; Timur O; Sarsik B; Akcicek F; Duman S
Nephrology (Carlton); 2011 Aug; 16(6):552-7. PubMed ID: 21382127
[TBL] [Abstract][Full Text] [Related]
19. SAHA Suppresses Peritoneal Fibrosis in Mice.
Io K; Nishino T; Obata Y; Kitamura M; Koji T; Kohno S
Perit Dial Int; 2015; 35(3):246-58. PubMed ID: 24584598
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-10 deficiency has protective effects against peritoneal inflammation and fibrosis via transcription factor NFκΒ pathway inhibition.
Ishimura T; Ishii A; Yamada H; Osaki K; Toda N; Mori KP; Ohno S; Kato Y; Handa T; Sugioka S; Ikushima A; Nishio H; Yanagita M; Yokoi H
Kidney Int; 2023 Nov; 104(5):929-942. PubMed ID: 37652204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
